Reference pricing, competition, and pharmaceutical expenditures : theory and evidence from a natural experiment
We study the impact of regulation on competition between brand-names and generics and pharmaceutical expenditures using a unique policy experiment in Norway, where reference pricing (RP) replaced price cap regulation in 2003 for a sub-sample of off-patent products. First, we construct a vertical dif...
| Autor principal: | |
|---|---|
| Outros Autores: | , |
| Formato: | article |
| Idioma: | eng |
| Publicado em: |
2011
|
| Assuntos: | |
| Texto completo: | http://hdl.handle.net/1822/11958 |
| País: | Portugal |
| Oai: | oai:repositorium.sdum.uminho.pt:1822/11958 |